BIB

Ultra Nasdaq Biotechnology

Investment Objective

ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.

You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB Market Price 0.85% 20.64% 17.16% 18.70% 29.48% -13.61% 8.23% 2.44% 16.53% 04/07/2010
BIB NAV 0.88% 20.71% 17.12% 18.57% 29.54% -13.61% 8.20% 2.43% 16.53% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Gross Expense Ratio
    1.15%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
Price
as of 9/26/2024
  • NAV
    $62.89
  • NAV Change
    $+1.02 up caret
  • Market Price
    $63.01
  • Market Price Change
    $+1.07 up caret
  • Trading Volume (M)
    18,183
  • 30-Day Median Bid Ask Spread
    0.00%
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Expense Ratio
    0.95%
  • Gross Expense Ratio
    1.15%
  • NAV Calculation Time
    4:00 p.m. ET
Price
as of 9/26/2024
  • NAV
    $62.89
  • NAV Change
    $+1.02 up caret
  • Market Price
    $63.01
  • Market Price Change
    $+1.07 up caret
  • Trading Volume (M)
    18,183
  • 30-Day Median Bid Ask Spread
    0.00%
  • View Premium / Discount

The expense ratio above has a contractual waiver ending 9/30/24.

Exposures

Index as of 6/28/2024

Holdings

as of 9/25/2024

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
45.87% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 39,736,064 -- 8,465 --
35.31% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 30,582,452 -- 6,515 --
25.72% -- NASDAQ BIO INDEX SWAP BNP 22,283,178 -- 4,747 --
7.16% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 6,200,985 -- 1,321 --
6.20% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 5,370,119 -- 1,144 --
6.18% GILD GILEAD SCIENCES INC -- $5,351,871.00 65,100 2369174
5.56% AMGN AMGEN INC -- $4,819,921.16 15,406 2023607
5.53% VRTX VERTEX PHARMACEUTICALS INC -- $4,788,912.96 10,371 2931034
5.17% REGN REGENERON PHARMACEUTICALS -- $4,476,222.15 4,341 2730190
4.80% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 4,159,026 -- 886 --
3.70% -- NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC 3,206,111 -- 683 --
3.25% AZN ASTRAZENECA PLC-SPONS ADR -- $2,815,167.24 36,306 2989044
2.52% ALNY ALNYLAM PHARMACEUTICALS INC -- $2,182,930.92 8,004 B00FWN1
1.98% BIIB BIOGEN INC -- $1,717,133.74 9,082 2455965
1.76% MRNA MODERNA INC -- $1,525,259.88 23,967 BGSXTS3
1.45% ILMN ILLUMINA INC -- $1,252,921.80 9,932 2613990
1.27% ARGX ARGENX SE - ADR -- $1,098,569.01 2,001 BDVLM39
1.19% SNY SANOFI-ADR -- $1,032,616.20 18,228 2964557
1.18% SMMT SUMMIT THERAPEUTICS INC -- $1,022,739.36 45,174 BMTVQS7
1.15% UTHR UNITED THERAPEUTICS CORP -- $997,280.74 2,774 2430412
0.97% VTRS VIATRIS INC -- $838,657.05 74,415 BMWS3X9
0.95% BMRN BIOMARIN PHARMACEUTICAL INC -- $819,267.40 11,870 2437071
0.91% PCVX VAXCYTE INC -- $789,568.14 6,959 BKPVGH6
0.90% INSM INSMED INC -- $779,355.53 10,715 2614487
0.89% RPRX ROYALTY PHARMA PLC- CL A -- $772,568.65 27,941 BMVP7Y0
0.88% INCY INCYTE CORP -- $759,145.76 12,008 2471950
0.86% SRPT SAREPTA THERAPEUTICS INC -- $740,990.52 5,946 B8DPDT7
0.83% NBIX NEUROCRINE BIOSCIENCES INC -- $721,206.80 6,296 2623911
0.82% BNTX BIONTECH SE-ADR -- $707,885.40 6,113 BK6H543
0.72% MEDP MEDPACE HOLDINGS INC -- $619,681.14 1,933 BDCBC61
0.66% BGNE BEIGENE LTD-ADR -- $570,340.48 2,759 BYYWPW6
0.63% ROIV ROIVANT SCIENCES LTD -- $542,691.16 46,108 BMW4NZ9
0.61% ASND ASCENDIS PHARMA A/S - ADR -- $528,327.24 3,612 BV9G6B8
0.57% ITCI INTRA-CELLULAR THERAPIES INC -- $489,949.56 6,588 BHCB0P4
0.54% RVMD REVOLUTION MEDICINES INC -- $467,216.90 10,415 BL71K91
0.54% EXEL EXELIXIS INC -- $463,477.10 17,785 2576941
0.51% HALO HALOZYME THERAPEUTICS INC -- $441,261.26 7,898 2975098
0.48% JAZZ JAZZ PHARMACEUTICALS PLC -- $415,261.00 3,850 B4Q5ZN4
0.45% CYTK CYTOKINETICS INC -- $386,460.48 7,336 BBBSBJ5
0.43% IONS IONIS PHARMACEUTICALS INC -- $373,664.84 9,116 BDJ0LS6
0.43% NUVL NUVALENT INC-A -- $371,765.45 3,701 BMVBZD3
0.40% BPMC BLUEPRINT MEDICINES CORP -- $343,650.00 3,950 BWY52P3
0.39% RNA AVIDITY BIOSCIENCES INC -- $335,526.90 7,302 BMWHPY1
0.38% RARE ULTRAGENYX PHARMACEUTICAL IN -- $326,142.96 5,746 BJ62Z18
0.37% KRYS KRYSTAL BIOTECH INC -- $321,538.23 1,791 BD6JX35
0.34% MDGL MADRIGAL PHARMACEUTICALS INC -- $292,748.34 1,354 BD59BS7
0.33% BBIO BRIDGEBIO PHARMA INC -- $287,355.24 11,724 BK1KWG8
0.33% ACLX ARCELLX INC -- $283,579.20 3,352 BPCJ1Q2
0.33% ADMA ADMA BIOLOGICS INC -- $283,228.68 14,532 B9NSBM2
0.31% ALKS ALKERMES PLC -- $271,356.81 10,267 B3P6D26
0.31% AXSM AXSOME THERAPEUTICS INC -- $269,130.56 2,993 BYZR4X4
0.30% IMVT IMMUNOVANT INC -- $259,360.92 9,126 BJRFSB7
0.30% DNLI DENALI THERAPEUTICS INC -- $258,854.00 8,926 BD2B4V0
0.29% CRNX CRINETICS PHARMACEUTICALS IN -- $251,745.50 4,990 BDD19F8
0.28% CRSP CRISPR THERAPEUTICS AG -- $243,835.20 5,310 BDHF4K6
0.27% APLS APELLIS PHARMACEUTICALS INC -- $232,269.87 7,593 BYTQ6X1
0.26% LEGN LEGEND BIOTECH CORP-ADR -- $221,800.15 5,093 BMX9K07
0.25% DYN DYNE THERAPEUTICS INC -- $218,348.80 6,260 BN15WD1
0.24% KYMR KYMERA THERAPEUTICS INC -- $209,122.11 4,027 BMPRZV5
0.23% MRUS MERUS NV -- $202,017.50 4,253 BZBY005
0.23% FOLD AMICUS THERAPEUTICS INC -- $201,192.96 18,492 B19FQ48
0.23% RYTM RHYTHM PHARMACEUTICALS INC -- $199,177.00 3,812 BF2YWG4
0.21% XENE XENON PHARMACEUTICALS INC -- $179,795.44 4,724 BRJ3GY4
0.20% PTCT PTC THERAPEUTICS INC -- $175,725.44 4,796 B17VCN9
0.20% IOVA IOVANCE BIOTHERAPEUTICS INC -- $174,479.28 18,924 BF0DMK7
0.20% AGIO AGIOS PHARMACEUTICALS INC -- $173,909.41 3,547 BCBVTX1
0.20% GH GUARDANT HEALTH INC -- $171,041.00 7,670 BFXC911
0.20% GERN GERON CORP -- $169,503.84 37,584 2370381
0.20% PTGX PROTAGONIST THERAPEUTICS INC -- $169,472.22 3,673 BDCBCD8
0.19% TWST TWIST BIOSCIENCE CORP -- $166,832.51 3,653 BGKG6G7
0.19% APGE APOGEE THERAPEUTICS INC -- $161,934.26 2,806 BM9HHL5
0.18% IDYA IDEAYA BIOSCIENCES INC -- $159,958.79 5,267 BK0VHF6
0.18% VCYT VERACYTE INC -- $159,713.15 4,789 BFTWZY0
0.18% ACAD ACADIA PHARMACEUTICALS INC -- $158,439.44 10,342 2713317
0.18% GPCR STRUCTURE THERAPEUTICS INC -- $155,844.25 3,715 BQS9486
0.18% JANX JANUX THERAPEUTICS INC -- $155,738.28 3,252 BMFX8Y7
0.18% IBRX IMMUNITYBIO INC -- $154,603.68 43,428 BNSP0B8
0.18% VERA VERA THERAPEUTICS INC -- $153,536.56 3,418 BL55460
0.17% EWTX EDGEWISE THERAPEUTICS INC -- $151,261.89 5,847 BKY5JZ8
0.17% SWTX SPRINGWORKS THERAPEUTICS INC -- $150,553.81 4,631 BGMGM89
0.17% ARWR ARROWHEAD PHARMACEUTICALS IN -- $150,524.42 7,751 BYQBFJ8
0.17% MYGN MYRIAD GENETICS INC -- $147,747.67 5,663 2614153
0.16% AMPH AMPHASTAR PHARMACEUTICALS IN -- $141,795.20 3,035 BNFWZS4
0.16% VCEL VERICEL CORP -- $135,119.40 3,057 BSBMN89
0.15% HRMY HARMONY BIOSCIENCES HOLDINGS -- $132,155.76 3,544 BKSGZN7
0.15% KROS KEROS THERAPEUTICS INC -- $132,036.55 2,339 BM7V485
0.15% NTLA INTELLIA THERAPEUTICS INC -- $131,061.44 6,333 BYZM6C2
0.15% VRNA VERONA PHARMA PLC - ADR -- $127,141.74 4,499 BYWPZK5
0.15% BEAM BEAM THERAPEUTICS INC -- $125,905.50 5,139 BK6L288
0.14% AKRO AKERO THERAPEUTICS INC -- $121,212.00 4,329 BK7Y2V9
0.14% NVAX NOVAVAX INC -- $120,183.28 9,982 BJDQXG4
0.14% RXRX RECURSION PHARMACEUTICALS-A -- $118,163.50 17,150 BM9FJ13
0.13% MIRM MIRUM PHARMACEUTICALS INC -- $115,956.26 2,974 BJDX8Y8
0.13% LGND LIGAND PHARMACEUTICALS -- $112,510.42 1,139 2501578
0.13% MNKD MANNKIND CORP -- $109,562.94 17,146 BF081J4
0.13% FTRE FORTREA HOLDINGS INC -- $108,815.28 5,586 BRXYZ57
0.12% NVCR NOVOCURE LTD -- $107,614.65 6,747 BYSS4X4
0.12% RCKT ROCKET PHARMACEUTICALS INC -- $104,760.50 5,675 BDFKQ07
0.12% SUPN SUPERNUS PHARMACEUTICALS INC -- $102,873.84 3,436 B72ZBG4
0.12% ARVN ARVINAS INC -- $101,264.80 4,280 BDZ30Q0
0.11% HROW HARROW INC -- $98,345.52 2,212 BHNDW86
0.11% BCRX BIOCRYST PHARMACEUTICALS INC -- $97,387.45 12,899 2100362
0.11% SNDX SYNDAX PHARMACEUTICALS INC -- $95,614.12 5,306 BN7Q7R7
0.11% NRIX NURIX THERAPEUTICS INC -- $94,496.48 4,016 BMVLGP2
0.11% KURA KURA ONCOLOGY INC -- $93,505.46 4,778 BYZD465
0.10% ARDX ARDELYX INC -- $89,101.53 14,679 BN89V40
0.10% IRON DISC MEDICINE INC -- $88,703.11 1,853 BMGJZJ8
0.10% DVAX DYNAVAX TECHNOLOGIES CORP -- $87,990.90 8,170 BRJZSK0
0.10% DAWN DAY ONE BIOPHARMACEUTICALS I -- $87,523.50 6,225 BLB0YH0
0.10% OCUL OCULAR THERAPEUTIX INC -- $85,942.48 9,722 BNZB1X8
0.10% SPRY ARS PHARMACEUTICALS INC -- $84,918.20 6,044 BMCR7V2
0.09% TARS TARSUS PHARMACEUTICALS INC -- $76,805.36 2,372 BMH5RL1
0.09% XNCR XENCOR INC -- $76,174.80 3,855 BGCYWN8
0.09% AVDL AVADEL PHARMACEUTICALS -- $76,165.38 6,002 BDGMC59
0.09% PHAT PHATHOM PHARMACEUTICALS INC -- $75,153.70 4,258 BJLKVS6
0.09% COLL COLLEGIUM PHARMACEUTICAL INC -- $75,099.20 2,008 BX7RSN3
0.09% ANIP ANI PHARMACEUTICALS INC -- $75,094.08 1,311 BCDWBX6
0.09% COGT COGENT BIOSCIENCES INC -- $74,245.12 6,824 BLR6XK8
0.09% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $73,890.60 2,410 BLCD809
0.08% INVA INNOVIVA INC -- $73,572.86 3,901 BDDXF67
0.08% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $71,490.60 8,826 BMCWKZ2
0.08% ELVN ENLIVEN THERAPEUTICS INC -- $71,357.35 2,945 BMFD115
0.08% WVE WAVE LIFE SCIENCES LTD -- $70,070.77 7,777 BYZG9R0
0.08% TVTX TRAVERE THERAPEUTICS INC -- $69,341.26 4,769 BLFGJD5
0.08% PRTA PROTHENA CORP PLC -- $68,468.26 3,353 B91XRN2
0.08% CNTA CENTESSA PHARMACEUTICALS-ADR -- $67,603.38 4,407 BLB0YQ9
0.08% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $66,320.80 7,288 BKX9VD3
0.08% GRFS GRIFOLS SA-ADR -- $65,867.96 7,606 B8K7T65
0.07% AUPH AURINIA PHARMACEUTICALS INC -- $64,188.00 8,915 BFWLC09
0.07% EOLS EVOLUS INC -- $63,219.38 3,934 BDRJH21
0.07% ZLAB ZAI LAB LTD-ADR -- $63,033.66 3,099 BD9GVY0
0.07% GMAB GENMAB A/S -SP ADR -- $62,291.62 2,614 BBC9WC7
0.07% VIR VIR BIOTECHNOLOGY INC -- $61,847.94 8,519 BK4PZ38
0.07% KNSA KINIKSA PHARMACEUTICALS INTE -- $61,021.20 2,532 BRXB0C0
0.07% ANAB ANAPTYSBIO INC -- $60,896.22 1,883 BDRW1L7
0.07% CGEM CULLINAN THERAPEUTICS INC -- $59,069.10 3,615 BM90J52
0.07% RLAY RELAY THERAPEUTICS INC -- $58,936.88 8,348 BN2R582
0.07% PETQ PETIQ INC -- $56,856.75 1,849 BDH65C8
0.06% ZYME ZYMEWORKS INC -- $55,419.30 4,430 BPCQZY9
0.06% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $54,031.90 2,314 BKDQKM6
0.06% SANA SANA BIOTECHNOLOGY INC -- $52,154.96 13,871 BMFJJ97
0.06% TNGX TANGO THERAPEUTICS INC -- $49,632.40 6,680 BP2P6L0
0.06% CSTL CASTLE BIOSCIENCES INC -- $49,449.40 1,729 BKLCWZ3
0.06% ETNB 89BIO INC -- $48,994.26 6,603 BK1K484
0.06% ERAS ERASCA INC -- $48,262.36 17,614 BNLYBF3
0.05% REPL REPLIMUNE GROUP INC -- $47,158.20 4,260 BDDVW37
0.05% ABUS ARBUTUS BIOPHARMA CORP -- $46,020.70 11,770 BZ0QMB7
0.05% ABCL ABCELLERA BIOLOGICS INC -- $44,827.68 18,372 BL53SR3
0.05% OLMA OLEMA PHARMACEUTICALS INC -- $44,268.00 3,570 BMZ4LN0
0.05% ORIC ORIC PHARMACEUTICALS INC -- $43,980.00 4,398 BKVDFF7
0.05% SRRK SCHOLAR ROCK HOLDING CORP -- $42,963.90 4,990 BFZQ0L8
0.05% PLRX PLIANT THERAPEUTICS INC -- $42,952.03 3,791 BMDWW66
0.05% AUTL AUTOLUS THERAPEUTICS PLC -- $42,938.70 12,446 BFMLGR4
0.05% CVAC CUREVAC NV -- $42,797.16 13,986 BN4RD42
0.05% SVRA SAVARA INC -- $42,591.45 10,263 BYXGN81
0.05% HUMA HUMACYTE INC -- $40,590.66 7,441 BMYTJP4
0.05% TERN TERNS PHARMACEUTICALS INC -- $40,589.00 4,388 BMDJ0C9
0.05% PCRX PACIRA BIOSCIENCES INC -- $40,005.16 2,876 B3X26D8
0.05% TRML TOURMALINE BIO INC -- $39,975.00 1,599 BQ80NC6
0.05% IRWD IRONWOOD PHARMACEUTICALS INC -- $39,142.80 9,960 B3MZ6K5
0.04% MLYS MINERALYS THERAPEUTICS INC -- $36,797.00 3,100 BP9N0G0
0.04% ADPT ADAPTIVE BIOTECHNOLOGIES -- $36,780.00 9,195 BJ5FZ74
0.04% FDMT 4D MOLECULAR THERAPEUTICS IN -- $36,547.20 3,240 BKLXFX5
0.04% GLPG GALAPAGOS NV-SPON ADR -- $36,074.56 1,264 B292NQ7
0.04% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $35,928.66 1,686 BKC9SX3
0.04% YMAB Y-MABS THERAPEUTICS INC -- $35,904.68 2,779 BG31GH0
0.04% RVNC REVANCE THERAPEUTICS INC -- $34,640.80 6,536 BJFSR99
0.04% THRD THIRD HARMONIC BIO INC -- $34,561.38 2,562 BNNPQY8
0.04% ALLO ALLOGENE THERAPEUTICS INC -- $34,159.56 13,038 BFZNYB7
0.04% LXRX LEXICON PHARMACEUTICALS INC -- $34,033.89 22,539 BWFZX59
0.04% HCM HUTCHMED CHINA-ADR -- $33,825.66 1,934 BYXV9H7
0.04% URGN UROGEN PHARMA LTD -- $33,770.36 2,626 BZ7PJQ1
0.04% RGNX REGENXBIO INC -- $33,367.23 3,081 BZ0G875
0.04% OABI OMNIAB INC -- $30,867.73 7,367 BN13S71
0.03% SIGA SIGA TECHNOLOGIES INC -- $30,037.50 4,450 2107437
0.03% ALEC ALECTOR INC -- $29,915.24 6,068 BJ4LDC4
0.03% SLRN ACELYRIN INC -- $29,745.94 6,223 BQPF874
0.03% AVXL ANAVEX LIFE SCIENCES CORP -- $28,814.15 5,287 BYTYP72
0.03% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $27,984.76 1,268 BL95N25
0.03% EYPT EYEPOINT PHARMACEUTICALS INC -- $27,196.55 3,337 BMGS7L1
0.03% PACB PACIFIC BIOSCIENCES OF CALIF -- $27,017.28 16,992 B4N8MH9
0.03% SAGE SAGE THERAPEUTICS INC -- $26,718.12 3,806 BP4GNK9
0.03% XERS XERIS BIOPHARMA HOLDINGS INC -- $26,012.00 9,290 BLR7H87
0.03% TSHA TAYSHA GENE THERAPIES INC -- $25,683.78 12,778 BNC1BX1
0.03% PRME PRIME MEDICINE INC -- $25,520.44 7,484 BPBJFM7
0.03% KALV KALVISTA PHARMACEUTICALS INC -- $25,409.56 2,686 BD06CS0
0.03% GRAL GRAIL INC -- $25,284.16 1,936 BSLSSX7
0.03% VERV VERVE THERAPEUTICS INC -- $25,166.52 5,276 BNKGXX2
0.03% MXCT MAXCYTE INC -- $24,963.12 6,552 BKMQF66
0.03% TBPH THERAVANCE BIOPHARMA INC -- $24,278.00 3,050 BMNDK09
0.03% ITOS ITEOS THERAPEUTICS INC -- $22,974.93 2,277 BMWXFT4
0.03% ACIU AC IMMUNE SA -- $22,752.54 6,166 BZC0D70
0.03% NAUT NAUTILUS BIOTECHNOLOGY INC -- $22,049.58 7,819 BNG1NK8
0.02% LYEL LYELL IMMUNOPHARMA INC -- $21,548.70 15,962 BN6MB18
0.02% BMEA BIOMEA FUSION INC -- $19,802.66 2,258 BNKF6N0
0.02% VYGR VOYAGER THERAPEUTICS INC -- $19,618.00 3,400 BY7RB53
0.02% MGTX MEIRAGTX HOLDINGS PLC -- $19,400.52 4,826 BFYQFJ2
0.02% AVIR ATEA PHARMACEUTICALS INC -- $18,055.52 5,264 BLN9Z50
0.02% VNDA VANDA PHARMACEUTICALS INC -- $17,624.90 3,634 B12W3P6
0.02% EDIT EDITAS MEDICINE INC -- $17,431.38 5,142 BZ8FPH3
0.02% ZNTL ZENTALIS PHARMACEUTICALS INC -- $16,671.84 4,434 BMQ5T49
0.02% PGEN PRECIGEN INC -- $16,568.46 17,939 BKM5C84
0.02% EXAI EXSCIENTIA PLC -- $15,954.56 3,104 BP48134
0.02% QURE UNIQURE NV -- $14,633.52 3,036 BJFSR88
0.02% AMRN AMARIN CORP PLC -ADR -- $14,145.52 24,948 2301938
0.02% FULC FULCRUM THERAPEUTICS INC -- $13,501.77 3,891 BJDX8Z9
0.02% AMLX AMYLYX PHARMACEUTICALS INC -- $13,244.40 4,245 BPCK358
0.01% ATAI ATAI LIFE SCIENCES NV -- $12,345.16 10,462 BN6M8F1
0.01% CABA CABALETTA BIO INC -- $12,031.70 3,046 BK5MWR1
0.01% MGNX MACROGENICS INC -- $11,889.44 3,911 BFDV8K0
0.01% CRBU CARIBOU BIOSCIENCES INC -- $10,648.26 5,634 BNYJR68
0.01% VTYX VENTYX BIOSCIENCES INC -- $10,530.34 4,406 BMG99Y1
0.01% CHRS COHERUS BIOSCIENCES INC -- $7,117.63 7,183 BRK0149
0.01% ME 23ANDME HOLDING CO -CLASS A -- $6,691.20 21,168 BM9CKX3
0.01% MRNS MARINUS PHARMACEUTICALS INC -- $5,975.16 3,434 BM8MVZ3
0.01% ALXO ALX ONCOLOGY HOLDINGS INC -- $5,944.04 3,284 BLN7XQ1
0.01% BLUE BLUEBIRD BIO INC -- $5,672.90 11,868 BBFL7S1
0.01% ACRS ACLARIS THERAPEUTICS INC -- $4,981.76 4,448 BYV2W40
0.01% OVID OVID THERAPEUTICS INC -- $4,956.00 4,425 BYPFK63
-- RAPT RAPT THERAPEUTICS INC -- $3,829.76 2,176 BK5T6R0
-- RPHM RENEO PHARMACEUTICALS INC -- $3,188.52 2,084 BMHR7T5
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $1,761.30 9,785 BM9HFX3
-- -- TREASURY BILL -- $9,912,572.90 10,000,000 BNNRNL0
-- -- TREASURY BILL -- $1,742,224.65 1,750,000 BN71QC0
-- -- NET OTHER ASSETS (LIABILITIES) -- $13,216,831.56 13,216,832 --

Index

as of 6/28/2024

  • Total Number of Companies215
  • Price/Earnings Ratio--
  • Price/Book Ratio4.157
  • Dividend Yield ( % )0.88
  • Avg. Index Market Capitalization$7.12 billion
About the Index

The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes securities of The Nasdaq Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc., including minimum market capitalization and liquidity requirements.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital

Portfolio Hedging Series

Part I: The Significance of Portfolio Hedging

Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.